The US Supreme Court will decide on the ownership of patents for methods of testing the effectiveness of AIDS treatments by measuring the HIV concentration in blood plasma, it announced on November 1.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at firstname.lastname@example.org
Supreme Court, Roche, AIDS treatments